Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Alongside this, researchers and pharmaceutical companies are accelerating development of dual- and triple-agonist candidates that combine GLP-1 effects with other hormone pathways, aiming to treat diabetes, obesity, and liver or kidney complications with a single medicine, thus marking a clear trend toward integrated metabolic-syndrome therapy
doi: 10.1007/s40263-016-0349-0
The brain is our species most precious commodity, responsible for making us the most successful animal on the planet
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic Silencing of ETS1
adults experienced mental illness in 2020 (52.9 million people)
\(\alpha \)-Tubulin was used as the loading control
US$ 24.26
US$ 22.79
US$ 22.81
